Teleflex Incorporated (TFX)
| Market Cap | 18.52B |
| Revenue (ttm) | 2.54B |
| Net Income (ttm) | 279.04M |
| Shares Out | 46.70M |
| EPS (ttm) | 5.89 |
| PE Ratio | 65.51 |
| Forward PE | 31.65 |
| Dividend | $1.36 |
| Dividend Yield | 0.35% |
| Trading Day | May 12 |
| Last Price | $385.96 |
| Previous Close | $400.72 |
| Change ($) | -14.76 |
| Change (%) | -3.68% |
| Day's Open | 397.30 |
| Day's Range | 384.78 - 402.17 |
| Day's Volume | 410,990 |
| 52-Week Range | 311.77 - 449.38 |
WAYNE, Pa., May 11, 2021 (GLOBE NEWSWIRE) -- May 11, 2021 – Thomas Powell, Executive Vice President and CFO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the UBS Global Healthcare Virtual...
WAYNE, Pa., May 03, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of co...
The acquisition of Z-Medica and an increase in sales of new products contribute to Teleflex's (TFX) revenue growth in Americas in Q1
Teleflex (TFX) delivered earnings and revenue surprises of 17.62% and 2.04%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Teleflex (NYSE:TFX) fell 0.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 5.51% year over year to $2.87, which beat the estimate o...
First quarter 2021 revenues of $633.9 million, up 0.5% versus prior year period on an as-reported basis; down 2.6% on a constant currency basis
WAYNE, Pa., April 27, 2021 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2021 Virtual Health Car...
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, April 29, 2021 Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, April 29, 2021
Teleflex (TFX) reported earnings 30 days ago. What's next for the stock?
UroLift® System, a proven treatment for Benign Prostatic Hyperplasia (BPH), now reimbursed in France
WAYNE, Pa.--(BUSINESS WIRE)--UroLift® System, a proven treatment for Benign Prostatic Hyperplasia (BPH), now reimbursed in France
WAYNE, Pa., March 10, 2021 (GLOBE NEWSWIRE) -- Jake Elguicze, Treasurer and Vice President of Investor Relations, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets ...
WAYNE, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven, minimally invasive...
Teleflex (TFX) witnesses significant sequential improvement in segmental performance during the fourth quarter on gradual recovery of the economy.
Teleflex (TFX) delivered earnings and revenue surprises of 7.26% and 3.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
WAYNE, Pa., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of c...
Fourth quarter 2020 revenues of $711.2 million, up 4.4% versus prior year period on an as-reported basis; up 2.3% on a constant currency basis
Submission is eligible for priority review and accelerated approval Submission is eligible for priority review and accelerated approval
WAYNE, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at Barclays Global Healthcare Conference on Tuesday, March...
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enrollment Completed Ahead of Schedule in Study Evaluating the Performance of Teleflex Specialty Catheters and Coronary Guidewires in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary In...
Company ranks as a top employer in the Mid-Size Employer and Health Care Equipment & Services categories Company ranks as a top employer in the Mid-Size Employer and Health Care Equipment & Services cat...
TeleFlex (TFX) Interventional business revenues are down due to the cancellation of certain non-emergent procedures.
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, February 25, 2021 Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, February 25, 2021
WAYNE, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that new data published in the peer-reviewed journal, European Urology Focus , found that men treated with...
Teleflex expands value of ErgoPack® Complete enhancements to critical vascular access products Teleflex expands value of ErgoPack® Complete enhancements to critical vascular access products
WAYNE, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 39th Annual J.P. Morgan Healthcare Conference on Tu...
Teleflex (TFX) to leverage its strength in enhancing clinical efficacy and patient safety via the recent buyout.
PARK CITY, Utah, Dec. 28, 2020 /PRNewswire/ -- DW Healthcare Partners ("DWHP") a healthcare-focused private equity firm, announced today the closing of its previously disclosed sale of Z-Medica ("Z-Medi...
WAYNE, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, announced today that it has completed the previously annou...
For the fourth consecutive year, Teleflex earned a top spot as a best place to work by United States sales professionals in the annual MedReps.com Best Places to Work Survey For the fourth consecutive y...
After a 65% rise since the March 23 lows of this year, at the current price of around $370 per share we believe Teleflex stock, best known for its single-use medical devices for common diagnostic and th...
New Findings Show UroLift System Same-Day Outpatient Procedure Demonstrates Symptom Improvement for Benign Prostatic Hyperplasia New Findings Show UroLift System Same-Day Outpatient Procedure Demonstrat...
Teleflex (TFX) expects further adverse financial impact of the coronavirus pandemic.
Teleflex (TFX) witnesses significant sequential improvement in segmental performance on gradual recovery of the economy.
WAYNE, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Stephens Investment Conference 2020, on Monday, Nov...
Teleflex Incorporated (TFX) CEO Liam Kelly on Q3 2020 Results - Earnings Call Transcript
Shares of Teleflex (NYSE:TFX) rose 0.1% in pre-market trading after the company reported Q3 results.
Teleflex (TFX) delivered earnings and revenue surprises of 22.03% and 1.27%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
WAYNE, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of c...
Third Quarter Revenues of $628.3 million, down 3.1% versus Prior Year Period on an As-Reported basis; down 4.1% on a Constant Currency basis
Signs Definitive Agreement to Acquire Linden Capital's Z-Medica Signs Definitive Agreement to Acquire Linden Capital's Z-Medica
WAYNE, Pa., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the expansion of its UroLift® System portfolio with the introduction of the UroLift® Advanced Tissue Contr...
Most important CVC update in a decade adds a variety of clinician-inspired enhancements Most important CVC update in a decade adds a variety of clinician-inspired enhancements
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, October 29, 2020 Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, October 29, 2020
Teleflex stock gained around 10% over the month to levels of around $362 currently. But will the company’s stock see higher prices over the coming weeks, or is a decline in the stock imminent?
Company ranks as a top employer in the state of Pennsylvania where its corporate headquarters are located Company ranks as a top employer in the state of Pennsylvania where its corporate headquarters ar...
Teleflex's (TFX) recent expanded indications for its IO device provide more time to physicians to establish safe vascular access.
Now Cleared for up to 48-Hour Dwell Now Cleared for up to 48-Hour Dwell
About TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional prod... [Read more...]
| Industry Medical Instruments & Supplies | Founded 1943 |
| Stock Exchange NYSE | Ticker Symbol TFX |
Financial Performance
In 2020, Teleflex's revenue was $2.54 billion, a decrease of -2.24% compared to the previous year's $2.60 billion. Earnings were $335.32 million, a decrease of -27.34%.
Analyst Forecasts
According to 12 analysts, the average rating for Teleflex stock is "Buy." The 12-month stock price forecast is 473.36, which is an increase of 22.64% from the latest price.